Cargando…
Quantitative Proteomics Analysis Identifies Mitochondria as Therapeutic Targets of Multidrug-Resistance in Ovarian Cancer
Doxorubicin is a widely used chemotherapeutic agent for the treatment of a variety of solid tumors. However, resistance to this anticancer drug is a major obstacle to the effective treatment of tumors. As mitochondria play important roles in cell life and death, we anticipate that mitochondria may b...
Autores principales: | Chen, Xiulan, Wei, Shasha, Ma, Ying, Lu, Jie, Niu, Gang, Xue, Yanhong, Chen, Xiaoyuan, Yang, Fuquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183995/ https://www.ncbi.nlm.nih.gov/pubmed/25285166 http://dx.doi.org/10.7150/thno.8502 |
Ejemplares similares
-
Quantitative proteomic analysis of mitochondria from human ovarian cancer cells and their paclitaxel-resistant sublines
por: Chen, Ming, et al.
Publicado: (2015) -
Integrated proteomic and N-glycoproteomic analyses of doxorubicin sensitive and resistant ovarian cancer cells reveal glycoprotein alteration in protein abundance and glycosylation
por: Ji, Yanlong, et al.
Publicado: (2017) -
Quantitative Proteomics Using Isobaric Labeling: A Practical Guide
por: Chen, Xiulan, et al.
Publicado: (2021) -
Comparative Proteomic Study of Fatty Acid-treated Myoblasts Reveals Role of Cox-2 in Palmitate-induced Insulin Resistance
por: Chen, Xiulan, et al.
Publicado: (2016) -
Comparative proteomic analysis of the mitochondria of menstrual stem cells and ovarian cancer cells
por: Chen, Xiuhui, et al.
Publicado: (2023)